Calixar invests €1 million in pipeline of highly druggable membrane protein targets and native antigens Read More » April 12, 2021
CALIXAR highlighted as a key player on the Global Difficult-to-Express Proteins Market in 2021 Read More » March 8, 2021
CALIXAR and the Austrian Institute of Technology, to improve the diagnosis of emerging and infectious diseases Read More » February 23, 2021
CALIXAR recognized as a major player on the global antibody engineering services market Read More » February 10, 2021
Solubilization and Stabilization of Native Membrane Proteins for Drug Discovery Read More » December 16, 2020
9th Annual Meeting of GDR3545: the CALIXAR Poster Prize has been awarded to Vaithish Velazhahan Read More » November 17, 2020
New extraction – stabilization compounds for membrane proteins isolation Read More » October 20, 2020
CALIXAR will meet international investors at the 20th Annual Biotech in Europe Forum, 21-24 Sept 2020 Read More » September 10, 2020
New publication to better understand the machinery around neurotransmitter receptor channels Read More » August 20, 2020
CALIXAR, industrial representative at FRISBI Industrial Days, Paris 3-4 February Read More » January 30, 2020
CALIXAR obtient le renouvellement de son agrément « Crédit d’Impôt Recherche » (CIR) pour 3 ans Read More » January 23, 2020
